Bormioli Pharma is a primary glass and plastic packaging manufacturer serving the pharmaceutical, biopharmaceutical and nutraceutical markets. The company’s products include dual-chamber systems, and are targeted towards drugs for oral, parenteral, ophthalmic and nasal delivery
Bormioli Pharma SpA
via Torrente Bratica
angolo via Sporzana
Phone / ContactT: +39 0521 362003
E: [email protected]
Bormioli Pharma is a primary glass and plastic packaging manufacturer serving the pharmaceutical, biopharmaceutical and nutraceutical markets with its integrated packaging offer comprising glass and plastic bottles, closures and accessories with applications in oral, parenteral, dual chamber, ophthalmic and nasal delivery.
With more than 40 years’ experience in the dual-chamber systems segment, Bormioli Pharma was one of the first packaging suppliers in the world to develop the bi-phase technology.
The company is ISO 9001 and ISO 15378 (GMP) certified, has five plants in Europe and more than 900 employees, producing over five billion packaging units that are distributed in 90 countries.
Bormioli Pharma was formed after the investment company Triton Investments Advisers LLP (London, UK ) acquired the pharma unit of glass manufacturer Bormioli Rocco (whose glass tableware business was simultaneously acquired by Luigi Bormioli SpA) from Vision Capital in 2017.